feed,title,long_url,short_url
Yahoo,Immunovant stock loses half its value after pausing dosing in trial of thyroid eye disease treatment,https://www.marketwatch.com/story/immunovant-stock-loses-half-its-value-after-pausing-dosing-in-trial-of-thyroid-eye-disease-treatment-2021-02-02?siteid=yhoof2&yptr=yahoo,https://on.mktw.net/3oIEYoZ
